Current through Register Vol. 49, No. 18, September 16, 2024
PURPOSE: This rule establishes definitions for
20 CSR
2150-5.026 to
20 CSR
2150-5.028 governing medication therapy services by
pharmacists.
(1) Definitions.
The following definitions shall apply for purposes of
20 CSR
2150-5.026 to
20 CSR
2150-5.028:
(A)
Authorizing physician(s)-The physician identified in the written protocol as
authorizing the pharmacist to provide medication therapy services;
(B) Health care entity-For purposes of this
rule, a health care entity shall be defined as any entity or organization that
is licensed or certified by the state or federal government as a hospital,
hospice facility, ambulatory surgical center, nursing home, long-term care
facility, residential care facility, assisted living facility, intermediate
care facility, skilled nursing facility, or a habilitation center as defined by
Chapter 630, RSMo, and that is required to maintain patient medical records by
state or federal law;
(C)
Medication therapy protocol-A written agreement between a physician and a
pharmacist for the provision of medication therapy services. A medication
therapy protocol shall comply with the provisions of
20 CSR
2150-5.028;
(D) Medication therapy services-The
designing, initiating, implementing, or monitoring of a plan to monitor the
medication therapy or device usage of a specific patient, or to enhance
medication therapeutic outcomes of a specific patient, by a pharmacist who has
authority to initiate or implement a modification of the patient's medication
therapy or device usage pursuant to a medication therapy protocol. For purposes
of
20 CSR
2150-5.026 to
20 CSR
2150-5.028, modification shall include selecting a
new, different, or additional medication or device, discontinuing a current
medication or device, or selecting a new, different, or additional strength,
dose, dosage form, dosage schedule, or route of administration for a current
medication or device, and implementing such selection(s). Medication therapy
services shall not include the sole act of dispensing a drug or device pursuant
to a valid prescription for the product, generic substitutions made pursuant to
section
338.056,
RSMo, or medication therapy management that does not include the initiation or
implementation of a modification of medication therapy, as provided
herein;
(E) Pharmacy resident-A
Missouri licensed pharmacist enrolled in a residency training program
accredited by the American Society of Health-System Pharmacists or a residency
training program with a valid application for accreditation pending with the
American Society of Health-System Pharmacists;
(F) Prescription order for medication
therapeutic plan-A lawful order that is issued by the authorizing physician
within the scope of his/her professional practice for the provision of
medication therapy services by a pharmacist for a specific patient, including,
patients of a health care entity; and
(G) Protocol-A medication therapy protocol,
as defined herein.
(2)
The provisions of
20 CSR
2150-5.026 to
20 CSR
2150-5.028 and
20 CSR
2220-6.060 to
20 CSR
2220-6.080 shall only be deemed applicable to persons
or entities under the jurisdiction of the Missouri State Board of Registration
for the Healing Arts and the Missouri State Board of Pharmacy, as established
by Chapter 334, RSMo, and Chapter 338, RSMo.
*Original authority: 334.125, RSMo 1959, amended 1993,
1995; 338.010, RSMo 1939, amended 1989, 1990, 2007, 2009, 2011 ; and 338.220,
RSMo 1951, amended 1969, 1981, 1989, 1997, 1999, 2001, 2004, 2007, 2009, 2011
.